Skip to content
Search

Latest Stories

As medicine shortages are found to be a Europe-wide problem, NPA calls for urgent action

Medicines shortages are a growing problem in the UK as well as across Europe, a recent survey has revealed.

According to a Pharmaceutical Group of European Union (PGEU) survey, pharmacy associations in most European countries admitted to having experienced medicine shortages in 2019, while 92 per cent of the countries reported shortages affecting patient's trust in community pharmacies.


In the majority of responding countries, over 200 medicines were listed as being in short supply and pharmacy staff were said to be spending an average of six hours per week on dealing with shortages.

The survey also identified a gap in information, tools and legal solution to community pharmacists in many European countries for providing the solution to patients in case of a shortage.

“All responding countries indicated that they believe medicine shortages caused distress and inconvenience to patients,” it further revealed.

NPA CALLS FOR URGENT ACTION

Commenting on the survey, the National Pharmacy Association (NPA) called for urgent action and said the data was further evidence of a widespread problem in the UK and across Europe.

“Because of heroic efforts by pharmacists, patients usually get their medicines when and where they need them, but longstanding faults in the medicines supply chain too often leave patients waiting. It’s time for urgent action, to reduce the risk of harm and to allow pharmacists to spend more time with patients instead of hunting for stock,” said NPA Policy Manager Helga Mangion.

More For You

Swizzels’ Easter range, including Squashies Drumchick and Sweet Shop Favourite tubs

PDA members will get the chance to vote from this week

Pic credit: iStock

PDA to inform its members to vote “no” in Royal College of Pharmacy proposals

A vote to create a potential Royal College of Pharmacy needs to be called off as the current proposals would lead to “irreversible change to the identity and purpose” of the sector’s professional leadership body, according to the Pharmacy Defence Association (PDA).

From March 13th to March 24th, The Royal Pharmaceutical Society’s members will take part in a Special Resolution Vote (SRV) which seeks to amend the Society’s Royal Charter to facilitate its transition to a Royal College and registered charity.

Keep ReadingShow less
Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less